伊宁曼品牌怎么样 申请店铺

更新时间:2024-10-18
伊宁曼是哪个国家的品牌?「伊宁曼」是 浙江海正药业股份有限公司 旗下著名品牌。该品牌发源于浙江,由创始人白骅在2001期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
伊宁曼怎么样

2011年,经中国药监局批准,海正药业正式推出非处方OTC药物伊宁曼奥利司他。

海正药业,全称浙江海正药业股份有限公司,创建于1956年,为国有控股上市公司,总部位于浙江省台州市,现有员工9000多人,是一家原料药、制剂研发、生产一体化的综合性、全球化制药企业,业务遍及全球70多个国家和地区。

作为国家首批创新型企业,海正建有国家认定的企业技术中心和博士后科研工作站、院士工作站。拥有化学药物、微生物药物、生物药物等六大研究所和药物筛选、菌种鉴定保藏、仪器分析、信息中心、EHS分析等中心。

海正药业是世界主要的奥利司他原料药供应商之一。目前,海正积极推进民族医药创新和国际化进程,不断推进海正的原料制剂一体化、制剂品牌化和生物产业化,从单一的原料药出口发展为原料药与自主品牌制剂同步。

海正围绕“生物药、化学药”两大领域开展自主品牌新药创制,在特色原料药产业化和高端制剂产业化等形成了特色和优势。

In 2011, with the approval of China food and drug administration, Haizheng pharmaceutical officially launched the over-the-counter OTC drug Yining manorista. Haizheng Pharmaceutical Co., Ltd., founded in 1956, is a state-owned holding listed company, headquartered in Taizhou City, Zhejiang Province, with more than 9000 employees. It is a comprehensive and global pharmaceutical enterprise integrating research and development of APIs, preparations, and production, with businesses in more than 70 countries and regions around the world. As one of the first batch of innovative enterprises in China, Haizheng has established enterprise technology center, postdoctoral research workstation and academician workstation recognized by the state. It has six research institutes of chemical drugs, microbial drugs and biological drugs, and centers of drug screening, strain identification and preservation, instrument analysis, information center, EHS analysis, etc. Haizheng pharmaceutical is one of the world's leading suppliers of orlista APIs. At present, Haizheng is actively promoting the process of innovation and internationalization of national medicine, constantly promoting the integration of raw materials and preparations, preparation branding and bio industrialization of Haizheng, and developing from a single export of raw materials to a synchronous development of raw materials and preparations of independent brands. Haizheng has developed its own brand new drug creation around the two major fields of "biological medicine and chemical medicine", and formed its characteristics and advantages in the industrialization of characteristic APIs and high-end preparations.

本文链接: https://brand.waitui.com/41c36cac2.html 联系电话:0576-88827890

千城特选小程序码

7×24h 快讯

韩国网络贷款银行k银行撤回了IPO计划

韩国网络贷款银行k银行撤回了IPO计划,据了解,k银行表示,它将在明年初再次寻求IPO。(财联社)

42分钟前

IDC:1~8月中国蓝牙耳机市场累计出货7338万台,同比增长19.5%

36氪获悉,国际数据公司(IDC)最新发布的报告显示,2024年1~8月中国蓝牙耳机市场累计出货量达到7338万台,同比增长19.5%。

42分钟前

易方达、中金等多机构确认获批参与互换便利操作

中国人民银行10月18日正式宣布,已联合证监会下发通知,即日起启动证券、基金、保险公司互换便利(SFISF)操作。目前有20家证券、基金公司获批参与工具操作,合计申请额度已超2000亿元。从业内获悉,易方达基金、华夏基金、中金公司、中信证券和华南某券商等头部基金、证券公司获准参与互换便利操作。其中,中信证券上报额度约100亿元。(21财经)

42分钟前

三星推迟接受部分阿斯麦芯片设备的交付

36氪获悉,据报道,三星推迟接受部分阿斯麦芯片设备的交付。(彭博)

42分钟前

创业板指涨逾8%,上涨个股近5000只

指数持续走强,创业板指拉升涨逾8%,沪指涨2.60%,深成指涨4.61%。算力链、半导体芯片、消费电子等方向涨幅居前,沪深京三市上涨个股近5000只。

42分钟前

本页详细列出关于伊宁曼的品牌信息,含品牌所属公司介绍,伊宁曼所处行业的品牌地位及优势。
咨询